Systematic review of outcome measures in trials of pediatric anaphylaxis treatment

BMC Pediatrics

Volumn 14, Issue 1, 2014, Pages

  Rubin, Tamar ^a   Clayton, Jacqueline ^a   Adams, Denise ^a   Jou, Hsing ^a   Vohra, Sunita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; GLUCOCORTICOID;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; CASE STUDY; CHILDHOOD DISEASE; CINAHL; COCHRANE LIBRARY; EMBASE; EMERGENCY WARD; EVIDENCE BASED PRACTICE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; CHILD;

ANAPHYLAXIS; CHILD; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84902702373     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-14-158     Document Type: Article

References (51)

1. Sinha I, Jones L, Smith RL, Williamson PR. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 2008, 5(4):e96.
2. Johnston BC, Shamseer L, da Costa BR, Tsuyuki RT, Vohra S. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010, 126:e222-e231.
3. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomized controlled trials on a cohort of systematic reviews. BMJ 2010, 340:c365.
4. Duncan PW, Jorgensen HS, Wade DT, . Outcome measures in acute stroke trials A systematic review and some recommendations to improve practice. Stroke 2000, 31:142-143. Outcome measures in acute stroke trials.
5. Clarke M. Standardizing outcomes for clinical trials and systematic reviews. Trials 2008, 8:39.
6. Williamson PR, Gamble C, Altman DG, Hutton JL. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005, 14(5):515-524.
7. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS 2011, 8:e1000393.
8. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, Brown SG, Camargo CA, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117:391-397.
9. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001, 108:861-866.
10. Kemp SF, Lockey RF. Anaphylaxis: a review of the causes and mechanisms. J Allergy Clin Immunol 2002, 110:341-348.
11. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002, 110:647-651.
12. Lieberman P. Allergy: Principles and Practice 2003, 1497-1522. St. Louis, Missouri: Mosby, Middleton , Adkinson , Yunginger , Busse , Bachner , Holgate , Simons , 6.
13. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, Decker WW, Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor AD, Hepner DL, Howarth M, Kaplan AP, Levy JH, Lewis LM, Lieberman PL, Metcalfe DD, Murphy R, Pollart SM, Pumphrey RS, Rosenwasser LJ, Simons FE, Wood JP, Camargo CA. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005, 115:584-591.
14. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001, 161(1):15-21.
15. Simons FER, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Müller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Imunol 2007, 120:S2-S4.
16. Simons FE, Sheikh A. Evidence-based management of anaphylaxis. Allergy 2007, 62:827-829.
17. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007, 119:1016-1018.
18. Greenberger PA, Rotskoff BD, Lifschult B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007, 98:252-257.
19. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007, 119:1018-1019.
20. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical Exp Allergy 2000, 30:1144-1150.
21. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000, 53:273-276.
22. Mink SN, Simons FE, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 2004, 34:1776-1783.
23. David JE, Norris RL. Allergic emergencies in children: the pivotal role of epinephrine. Pediatr Emerg Med Pract 2007, 4:1-28.
24. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005, 95:217-226.
25. Sheikh A, ten Broek VM, Brown SGA, Simons FE. H1antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007, 1:CD006160.
26. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2008, 4:CD006312.
27. Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012, CD007596.
28. Schulz KF, Altman DG, Moher D, . for the CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Int Med 2010, 152(11):726-732. for the CONSORT Group.
29. Ellis C. Emergency Department Anaphylaxis Trial II B preliminary trial to confirm pharmacokinetic profiles and study feasibility in patients with anaphylaxis treated with either intramuscular vs. intravenous adrenaline. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000282987 (accessed 5 Mar 2013).
30. Park JH, Godbold JH, Chung D, Sampson HA, Wang J. Comparison of cetirizine to diphenhydramine in the treatment of acute food allergic reactions. J Allergy Clin Immunol 2011, 128:1127-1128.
31. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004, 21:149-154.
32. Edwards ES, Gunn R, Simons ER, Carr K, Chinchilli VM, Painter G, Goldwater R. Bioavailability of epinephrine from Auvi-Q compared with EpiPen. Ann Allergy Asthma Immunol 2013 Aug, 111(2):132-137.
33. Heilborn H, Hjemdahl P, Daleskog M, Adamsson U. Comparison of subcutaneous injection and high-dose inhalation of epinephrine - implications for self-treatment to prevent anaphylaxis. J Allergy Clin Immunol 1986, 76:1174-1179.
34. Simon FER. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998, 101:33-37.
35. Johnston SL, Unsworth J, Gompels M. Adrenaline given outside the context of life threatening allergic reactions. BMJ 2003, 326:589-90.
36. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS, . Vaccine Safety Datalink Team Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004, 113:536-42. Vaccine Safety Datalink Team.
37. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3 year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004, 34:285-90.
38. Sampton HA, Mendelson L, Rosen JP. Fatalities due to anaphylactic reactions to food. J Allergy Clin Immunol 1992, 327:380-384.
39. Bautista E, Simons FER, Simons KJ, Becker AB, Duke K, Tillett M, Kepron W, Mink SN. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Appl Immunol 2002, 128:151-164.
40. Yunginger JW, Squillace DL, Jones RT, Helm RM. Fatal anaphylactic reactions induced by peanuts. Allergy Proc 1989, 10:249-253.
41. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001, 107:191-3.
42. Yunginger JW, Sweeney KG, Sturner WQ, Giannandra LA, Teigland JD, Bray M, Benson PA, York JA, Biedrzycki L, Squuillace DL, Helm RM. Fatal food-induced anaphylaxis. JAMA 1988, 260:1450-1452.
43. Boyce JA, Assa'ad A, Burks W, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. Nutr Res 2011, 31:61-75.
44. Russell S, Monroe K, Losek JD. Anaphylaxis Management in the Pediatric Emergency Department: opportunities for Improvement. Pediatr Emerg Care 2010, 26:71-6.
45. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004, 114:371-376.
46. Waserman S, Chad Z, Francoeur MJ, Small P, Stark D, Vander Leek TK, Kaplan A, Kastner M. Management of anaphylaxis in primary care: Canadian expert consensus recommendations. Allergy 2010, 65:1082-1092.
47. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 2010,
48. WMA Declaration of Helsink in: ethical principles for medical research involving human subjects. 2008, http://www.wma.net/en/30publications/10policies/b3/ (accessed 5 Mar 2013).
49. Title 45 Public Welfare Department of Health and Human Services. Part 46 protection of human subjects. Revised June 23 2005; effective June 23 2005; http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html (accessed 5 Mar 2013), Title 45 Public Welfare.
50. Habib GB, Dunbar LM, Rodrigues R, Neale AC, Friday KJ. Evaluation of the efficacy and safety of oral nicardipine in treatment of urgent hypertension: a multicenter, randomized, double-blind, parallel, placebo controlled clinical trial. Am Heart J 1995, 129:917-923.
51. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.